I spent 30 years in pharmaceutical business across different therapeutic areas and markets accumulating experience in a wide range of areas. Since 2011 fully engaged in orphan diseases, I have crafted two successful start-ups in new therapeutic areas managing at same time internal resources as well as external commercial partnerships. My extensive network in the pharma field across geographies would allow for further similar experiences.
Since March 2018
Interested in new projects possibly EU-based in the field of rare/orphan diseases, quality and good vibes over flashy titles, I like hands-on roles and love hiring great people!
Chief Commercial Officer
February 2015 --- March 2018
CCO EU and RoW in Santhera, I have built from scratch the commercial organisation and successful launched the lead compound Raxone® (INN: idebenone - registered in Leber's Hereditary Optic Neuropathy) in the EU and Israel, reaching and surpassing company targets. Raxone is currently under EU review for Duchenne Muscular Dystrophy (DMD). More about it on www.santhera.com.
Senior Vice President, Mid-Sized Countries
November 2011 --- January 2015
Brilliant start-up experience as SVP Mid-Size Countries. I supervised 3 EU clusters and the expansion project outside EU. In this function I built and managed an outstanding team of 30 colleagues, surpassing company expectations for the launch of Esbriet; covered - ad interim - the position of Country Manager Italy between Nov. '12 - Mar. '13. InterMune was acquired by Roche in the summer of 2014.
Senior Vice President, New Markets
June 2010 --- November 2011
Senior VP in the New Market region, reporting directly into Eisai WW HQ in Tokyo, Japan. Carried out pivotal entries in Russia and Turkey as well as contracting third parties in additional geographies.
April 2009 --- June 2010
P&L Mid-size affiliates responsability in EU, existing distributors management and expansion projects in enlarged EU, including CIS and Mediterranean area.
Managing Director Italy
March 2005 --- March 2009
Start-up of the company (Italian affiliate of the Japanese multinational) during spring '05. Office based in San Donato Milanese (Milan, Italy). Affiliate profitable from 1st year with 70 full time employees. 3 successful price negotiations in 2 years.
General Manager Italy
January 2003 --- January 2005
P&L responsability for the Italian branch of the Danish multinational, world leader in allergy vaccine therapy. A much needed directional change allowed for claiming back, after years, market leadership, rebuilding a professional team in the field of allergy.
Business Unit Director Italy
January 2001 --- January 2003
Retail business unit marketing also specialist products to selected targets.
Various positions in sales and marketing
January 1988 --- January 2001
Intl. Mktg and sales in US, Antinfective Mktg. Dir. Europe, Oncology Dir. in Spain, Retail Sales Manager in Italy
Veterinary medicine in Medical Clinical Sciences/Graduate Medical Studies from Universita' degli Studi di Sassari in 1986
Licenza liceale in from Liceo Classico D.A. Azuni in 1978